Abstract
Aged SJL mice spontaneously develop a B-cell malignancy, which has been compared with human follicular center cell lymphoma, an inevitably fatal disease despite conventional therapy (1–4). SJL lymphomas provide a model for development of a new treatment for this disease by revealing the existence of a novel target for therapy, nonmalignant lymphocytes upon which the tumor cells are dependent for growth (5).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Murphy ED: SJL/J, a new inbred strain of mouse with a high early incidence of reticulum cell neoplasms. Proc. AACR 4:46, 1963.
Wanebo HJ, Gallmeir WM, Boyse EA, Old LJ: Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science 154:901–903, 1966.
Pattengale PK, Taylor CR: Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin’s lymphomas and related leukemias. Am. J. Pathol. 113:237–265, 1983.
Rosenberg SA: Karnofsky memorial lecture. The low-grade non-Hodgkin’s lymphomas: Challenges and opportunities. J. Clin. Oncol. 3:299–310, 1985.
Ponzio NM, Brown PH, Thorbecke GJ: Host-tumor interactions in the SJL lymphoma model. Int. Rev. Immunol. 1:273–301, 1986.
Lerman SP, Carswell EA, Chapman J, Thorbecke GJ: Properties of reticulum cell sarcomas in SJL/J mice. III. Promotion of tumor growth in irradiated mice by norma 1 lymphoid cells. Cell. Immunol. 23: 53–67, 1976.
Lerman SP, Chapman-Alexander J, Umetsu D, Thorbecke GJ: Properties of reticulum cell sarcomas in SJL/J mice. VII. Nature of normal lymphoid cells proliferating in response to tumor cells. Cell. Immunol. 43:209–213, 1979.
Lasky JL, Thorbecke GJ: Characterization and growth factor requirements of SJL lymphomas. II. Interleukin-5 dependence of the in vitro cell line cRCS-X, and influence of other cytokines. Eur. J. Immunol. 19:365–371, 1989.
Ohnishi K, Bonavida B: Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation. J. Immunol. 138:4524–4529, 1987.
Aliasaukas RM, Ponzio NM: T-helper cell specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J mice. Cell. Immunol. 119:286–303, 1989.
Thrush GR, Placey JL, Valeriote FA, Lerman SP: The CD4 cell dependency of SJL/J B-cell lymphomas as a target for cyclophosphamide therapy. Cancer Comm. 1:301–310, 1989.
Smith KA: Interleukin-2: Inception, impact, and implications. Science 240:1169–1176, 1988.
Butterfield K, Fathman CG, Budd RC: A subset of memory CD4+ helper T lympocytes indentified by expression of Pgp-1. J. Exp. Med. 169:1461–1466, 1989.
MacDonald HR, Budd RC, Cerottini JC: Pgp-1 (Ly 24) as a marker of murine memory T lymphocytes. Current Topics Microbiol. Immunol. 159:97–109, 1990.
Sopchak L, King SR, Miller DA, et al: Progression of transplanted SJL/J lymphomas attributed to a single aggressive H-2DS negative lymphoma. Cancer Res. 49:665–671, 1989.
Rosloniec EF, Kuhn MH, Genyea CA, et al: Aggressiveness of SJL/J lymphomas correlates with absence of H-2DS antigens. J. Immunol. 132:945–952, 1984.
Budd RC, Cerottini J-C, Horvath C, et al: Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 13 8:3120–3129, 1987.
Ponzio NM, Lerman SP, Chapman JM, Thorbecke GJ: Properties of reticulum cell sarcomas in SJL/J mice. IV. Minimal development of cytotoxic cells despite marked proliferation to syngeneic RCS in vivo and in vitro. Cell. Immunol. 32:10–22, 1977.
Roa A: Signaling mechanisms in T cells. Critical Reviews Immunol. 10:495–519, 1991.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Cankovic, M., Wrone-Smith, T., VanBuren, E., Lerman, S. (1996). SJL Model for Lymphoma Treatment. In: Valeriote, F.A., Nakeff, A., Valdivieso, M. (eds) Basic and Clinical Applications of Flow Cytometry. Developments in Oncology, vol 77. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1253-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1253-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8534-2
Online ISBN: 978-1-4613-1253-6
eBook Packages: Springer Book Archive